DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP DIN 00619698
Health Canada record
| Active ingredient(s) | DOPAMINE HYDROCHLORIDE 1.6 MG; DEXTROSE 50 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01CA04 DOPAMINE |
| Original market date | 31-Dec-1986 |
| Current status date | 30-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hospira Healthcare India Pvt. Ltd. — licence , not currently licensed, last inspection rating NC (2017-07-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOPAMINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00761850 | DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | DOPAMINE HYDROCHLORIDE 0.8 MG; DEXTROSE 50 MG | Marketed |
| 00761826 | DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | DOPAMINE HYDROCHLORIDE 1.6 MG; DEXTROSE 50 MG | Marketed |
| 00761834 | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | DOPAMINE HYDROCHLORIDE 3.2 MG; DEXTROSE 50 MG | Marketed |
| 00423823 | DOPAMINE HCL INJ 4% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | DOPAMINE HYDROCHLORIDE 40 MG | Cancelled Post Market |
| 00782394 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | DOPAMINE HYDROCHLORIDE 3.2 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 00619701 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | DOPAMINE HYDROCHLORIDE 0.8 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 01914014 | INTROPIN INJECTION 40MG/ML | BRISTOL-MYERS SQUIBB CANADA | Solution | DOPAMINE HYDROCHLORIDE 40 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 2179 | 2004-05-05 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for DOPAMINE HYDROCHLORIDE
3 valid EDQM Certificates of Suitability from 3 holders. 1 active FDA Drug Master Files.
Request a quote for DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP